Gene · 3672
Papers3,336
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,336
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. | Int J Mol Sci | 2022 | 36361831 | PubTator, text mining | PubMed |
| Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? | Int J Mol Sci | 2022 | 36361639 | PubTator, text mining | PubMed |
| Effects of Dentin Phosphophoryn-Derived RGD Peptides on the Differentiation and Mineralization of Human Dental Pulp Stem Cells In Vitro. | Biomedicines | 2022 | 36359301 | PubTator, text mining | PubMed |
| Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities. | Clin Immunol | 2022 | 36356848 | PubTator, text mining | PubMed |
| MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis. | Sci Rep | 2022 | 36344812 | PubTator, text mining | PubMed |
| Single-cell sequencing technologies in bladder cancer research: Applications and challenges. | Front Genet | 2022 | 36338973 | PubTator, text mining | PubMed |
| The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors. | Explor Target Antitumor Ther | 2022 | 36338516 | PubTator, text mining | PubMed |
| The genus Porana (Convolvulaceae) - A phytochemical and pharmacological review. | Front Pharmacol | 2022 | 36330088 | PubTator, text mining | PubMed |
| 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution. | J Adv Res | 2022 | 36328741 | PubTator, text mining | PubMed |
| Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b. | iScience | 2022 | 36310646 | PubTator, text mining | PubMed |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. | Cancer Cell | 2022 | 36306792 | PubTator, text mining | PubMed |
| Non-Invasive and Mechanism-Based Molecular Assessment of Endometrial Receptivity During the Window of Implantation: Current Concepts and Future Prospective Testing Directions. | Front Reprod Health | 2022 | 36303672 | PubTator, text mining | PubMed |
| Basigin is necessary for normal decidualization of human uterine stromal cells. | Hum Reprod | 2022 | 36303457 | PubTator, text mining | PubMed |
| Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma. | Metab Brain Dis | 2022 | 36301458 | PubTator, text mining | PubMed |
| Establishment of inclusive single-cell transcriptome atlases from mouse and human tooth as powerful resource for dental research. | Front Cell Dev Biol | 2022 | 36299483 | PubTator, text mining | PubMed |
| Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration. | Front Bioeng Biotechnol | 2022 | 36299288 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. | Pharmaceutics | 2022 | 36297643 | PubTator, text mining | PubMed |
| Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. | Cancers (Basel) | 2022 | 36291830 | PubTator, text mining | PubMed |
| Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals. | J Clin Invest | 2022 | 36282594 | PubTator, text mining | PubMed |
| Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates. | Front Immunol | 2022 | 36275702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3672/papers?page=32